Medicines planning
47 results
Applied filters
National Homecare Medicines Committee (NHMC) Homecare Service Proposal (HSP) Form
25 November 2021Find and download the NHMC Homecare Service Proposal form.
National Homecare Medicines Committee (NHMC) Terms of Reference
5 April 2018Find attached the terms of reference for the NHMC subgroups
National Homecare Medicines Committee (NHMC) homecare digital strategy
4 August 2020Find attached the NHMC homecare digital strategy
National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice
4 August 2020Explanation of engagement with the National Homecare Medicines Committee for manufacturers
Biosimilar insulin: a primary care discussion
1 July 2026A discussion about the considerations of implementing biosimilar insulin in primary care.
The licence and supporting evidence for omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
The licence and supporting evidence for ranibizumab biosimilars
5 November 2025Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
The licence and supporting evidence for golimumab biosimilar
2 June 2026We highlight evidence for available golimumab biosimilar(s) and differences between the biosimilar(s) and the reference product (Simponi).
Preparing to use ustekinumab biosimilar
31 July 2026Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
The licence and supporting evidence for ustekinumab biosimilars
31 July 2026Ustekinumab biosimilars are available for use within the NHS. Learn about indications, formulations, supporting evidence and differences.